|
Mar 3
|
Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
|
|
Mar 3
|
Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
|
|
Mar 3
|
4 Stocks Trading Near 52-Week High With More Upside Potential
|
|
Feb 28
|
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Growth Stock: Should You Buy?
|
|
Feb 28
|
International Markets and Jazz (JAZZ): A Deep Dive for Investors
|
|
Feb 28
|
Jazz Pharmaceuticals plc Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
|
|
Feb 26
|
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term
|
|
Feb 26
|
Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%
|
|
Feb 26
|
Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Feb 25
|
Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics
|
|
Feb 25
|
Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates
|
|
Feb 25
|
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales
|
|
Feb 25
|
Jazz: Q4 Earnings Snapshot
|
|
Feb 25
|
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance
|
|
Feb 24
|
Jazz Pharmaceuticals (JAZZ) Reports Earnings Tomorrow: What To Expect
|
|
Feb 20
|
Jazz Pharmaceuticals to Participate in TD Cowen's 45th Annual Health Care Conference
|
|
Feb 20
|
Jazz (JAZZ) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
|
Feb 12
|
Jazz (JAZZ) Surges 5.2%: Is This an Indication of Further Gains?
|
|
Feb 11
|
Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025
|
|
Oct 2
|
Here's Why You Should Consider Buying Jazz Pharmaceuticals' Stock
|